Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...
Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...
Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.
Investing.com -- Cyclerion Therapeutics Inc (NASDAQ:CYCN) stock soared 44.2% in after-hours trading Monday following the announcement of a strategic collaboration with Medsteer to advance its ...
Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
Everyday Health on MSN
We tested over 65 online therapy companies — these 11 were the most affordable we actually would recommend
After testing over 65 therapy services to find the best options, we believe these 11 most affordable online therapy services ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
MedPage Today on MSN
Fish oil flopped for kids with major depressive disorder
Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...
Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback